DFPG Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,166
Closed -$363K 178
2021
Q4
$363K Sell
2,166
-14,131
-87% -$4.13M 0.15% 112
2021
Q3
$5.41M Buy
16,297
+362
+2% +$134K 2.05% 13
2021
Q2
$3.75M Sell
15,935
-11,212
-41% -$2M 1.42% 19
2021
Q1
$3.53M Buy
27,147
+1,162
+4% +$168K 1.51% 17
2020
Q4
$2.22M Buy
25,985
+5,900
+29% +$597K 1.02% 22
2020
Q3
$1.45M Buy
20,085
+50
+0.2% +$3.49K 0.78% 32
2020
Q2
$1.22M Buy
+20,035
New +$1.1M 0.75% 34

Other funds holding MRNA

DFPG Investments's MRNA Position: Q1 2022 in Review

DFPG Investments sold out of Moderna (MRNA) in Q1 2022, closing a stake of 2,166 shares — an estimated $363K sold.

DFPG Investments first reported a position in MRNA in Q2 2020 and held it in 7 quarters. The position peaked at $5.41M in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • DFPG Investments reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • DFPG Investments sold 2,166 Moderna shares in Q1 2022, an estimated $363K.
  • DFPG Investments first reported a position in Moderna in Q2 2020 and held it in 7 quarters.
  • DFPG Investments's Moderna position peaked at $5.41M in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on DFPG Investments's 13F filing for Q1 2022, filed 22 Apr 2022.